Gain Therapeutics
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $82 | $0 |
Gross Profit | -20 | -21 | -21 | |
EBITDA | -5,089 | -4,369 | -3,309 | -4,437 |
EBIT | -5,089 | -4,390 | -3,331 | -4,458 |
Net Income | -5,809 | -4,530 | -3,768 | -4,485 |
Net Change In Cash | 0 | 0 | 82 | 0 |
Free Cash Flow | 3,821 | -3,821 | -3,455 | -6,076 |
Cash | 6,694 | 9,070 | 10,385 | 12,049 |
Basic Shares | 30,341 | 28,685 | 27,132 | 26,531 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $55 | $140 | $164 |
Gross Profit | -84 | -25 | 75 | -6,999 |
EBITDA | -19,790 | -22,169 | -17,777 | -13,822 |
EBIT | -19,874 | -22,253 | -17,841 | -13,837 |
Net Income | -20,411 | -22,267 | -17,590 | -13,890 |
Net Change In Cash | 0 | 55 | 140 | 164 |
Cost of Revenue | -29,545 | |||
Free Cash Flow | -18,896 | -18,881 | -14,811 | -12,459 |
Cash | 10,385 | 11,794 | 7,311 | 36,880 |
Basic Shares | 22,881 | 13,011 | 11,883 | 10,165 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | -$0.19 |
2025-03-31 | -$0.16 |
2024-12-31 | -$0.08 |
